Эффективность сальгима при стационарном лечении бронхиальной астмы

Утешев Даниил Борисович, А. А. Карабиненко, В. И. Светлаков et al. · Пульмонология · 2021

An investigation of clinical efficacy, safety and dispensation in airways of 0.1% salbutamol hemisuccinate nebulized solution was performed in moderate to severe bronchial asthma patients under a 10-day inpatient treatment. The analysis showed the Russian β 2 -agonist to be an effective medication for bronchial asthma inpatient treatment. It fits to all safety requirements and has the equal efficacy but more beneficial cost-effectiveness compared with the foreign analog Ventolin.

Cited by 0 works.

Authors